Systemic Review: Ozone: A Potential New Chemotherapy
Type: Journal article
Author: Jose Baeza-Noci * and Rosa Pinto-Bonilla
The use of ozone in cancer needs still a lot of preclinical investigation not only by testing more cancer cell lines but also testing different ozone dosages, as we presently know that all cancer cell lines are not equally affected by ozone. In vivo studies have been mainly devoted to systemic ozone with low doses. It is mandatory to develop more animal studies following Kuroda’s investigational line, or with intratumoral ozone gas injection.